PRIMA US-Feasibility Study in Atrophic Dry AMD
NCT: NCT03392324 · ACTIVE_NOT_RECRUITING
NCT IDNCT03392324
StatusACTIVE_NOT_RECRUITING
Start Date2018-04-26
Completion2026-09
Brief Summary
In this early feasibility trial the safety and performance of the new retinal prothesis PRIMA is tested in five subjects suffering from atrophic dry age related macular degeneration.
Frequently Asked Questions
What is PRIMA US-Feasibility Study in Atrophic Dry AMD?
PRIMA US-Feasibility Study in Atrophic Dry AMD is a clinical trial registered under NCT03392324. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03392324?
The current status of NCT03392324 (PRIMA US-Feasibility Study in Atrophic Dry AMD) is: ACTIVE_NOT_RECRUITING.
When did PRIMA US-Feasibility Study in Atrophic Dry AMD start?
PRIMA US-Feasibility Study in Atrophic Dry AMD started on 2018-04-26.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.